With our focus on improving patient outcomes with evidence-based healing solutions, we develop, market and distribute wound and skincare products to physicians, hospitals, clinics and all post-acute care settings.
Featured Product
CellerateRX® Surgical Powder
CellerateRX® Surgical Powder aids in the management of surgical wounds. When applied to a surgical wound, the hydrolyzed collagen is ready to aid in the natural wound healing process.
AN ADJUNCT TO YOUR SURGICAL PROCEDURES
CellerateRX Surgical Powder is a medical hydrolysate of Type I bovine collagen indicated for the management of:
- Surgical wounds
- Traumatic wounds
- Partial- and full-thickness wounds
- First- and second-degree burns
The Added Edge of Hydrolyzed Collagen
- Sterilized and packaged for use in a sterile, surgical environment
- Provides the benefits of hydrolyzed collagen to the wound bed
- Hydrolyzed collagen fragments do not have to be broken down before use
- Versatile, can be used in many types of surgical wounds
- Three-year shelf life
Appropriate for Many Surgical Specialties including:
Orthopedic, Vascular, Plastic / reconstructive, Obstetric / gynecologic, Sports medicine, Neurologic, Trauma, Cardiovascular, General, Burn surgeons, Podiatry, Spine
Sanara MedTech Executives
Zach Fleming | Chief Executive Officer
Zach was appointed to Chief Executive Officer in January 2022. Mr. Fleming joined Sanara MedTech as Vice President of Sales in November 2017 and was promoted to Vice President, Surgical in September 2018. Zach successfully led the surgical sales organization to growth and was responsible for the management of the expansion of the surgical sales force. Zach was promoted to President of the Surgical Division, in May 2019 and as Co-Chief Operating Officer in January 2020. In these roles, he has overseen double-digit year over year revenue growth of our business. Prior to Sanara, Mr. Fleming held several sales and management roles at Healthpoint Biotherapeutics, and Smith & Nephew. Zach earned a Bachelor of Science from Indiana University.
Shawn Bowman | President and Chief Operating Officer, Wound Care Division
Shawn was appointed to the position of President, Wound Care Division in May 2019 and will lead the strategic expansion of wound care. Shawn previously served as the Company’s Vice President and General Manager, Wound Care since September 2018. He is a well-respected leader in chronic wound care with eighteen years of key experience in the medical device, biologics and pharmaceutical industries. Prior to joining Sanara MedTech, Shawn built two successful teams as Senior Vice President of Wellsense, and as a National Sales Director for Smith & Nephew’s Advanced Wound Management Division. Shawn earned a Bachelor of Science in Marketing from the University of Connecticut.
Mike McNeil | Chief Financial Officer
Mike has served as Chief Financial Officer since April 2018. Prior to joining the Company, Mr. McNeil served as Controller for Smith and Nephew’s U.S. Advanced Wound Management Division from 2012 to 2018. Mr. McNeil previously served as Controller and Assistant Controller with Healthpoint Biotherapeutics from 1999 to 2012. Prior to his employment at Healthpoint, Mr. McNeil held several finance and internal audit positions with Burlington Resources, Snyder Oil Corporation, and Union Pacific Corporation. Mr. McNeil earned his Bachelor of Science in Business Administration from the University of Nebraska and is a Texas certified public accountant.
